AN2 Therapeutics Ownership & Insider Activity

AN2 Therapeutics (ANTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.1% of shares outstanding. Institutional investors hold 15.6%. Over the past 90 days, insiders made 1 purchase worth $12K and 5 sales worth $330K.

Shares Outstanding

37.736M

Shares Float

31.792M

Insider Shares Owned

1.468M

Insider % Owned

4.1%

Institutional Shares Held

5.903M

Institutional % Held

15.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$12K total

Sales (90d)

$330K total

Net Activity

Net Selling

Net Value (90d)

-$319K

AN2 Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Nov 5, 2026	Joshua M Eizen	SEE REMARKS	SELL	2.826K	$4.22	$12K
Sep 9, 2026	Robin Shane Readnour	—	SELL	1.108K	$6.02	$7K
Sep 3, 2026	Robin Shane Readnour	—	SELL	16.119K	$6.04	$97K
Sep 1, 2026	Sarah Joanne Williams	PRINCIPAL ACCOUNTING OFFICER	SELL	272.000	$5.53	$2K
Sep 1, 2026	Margaret M FitzPatrick	—	BUY	2.098K	$5.53	$12K
Aug 17, 2026	Robin Shane Readnour	—	SELL	35.402K	$6.01	$213K
Jul 8, 2026	Joshua M Eizen	SEE REMARKS	SELL	5.945K	$4.17	$25K
May 29, 2026	Sarah Joanne Williams	PRINCIPAL ACCOUNTING OFFICER	SELL	265.000	$4.43	$1K

AN2 Therapeutics Inc

AN2 Therapeutics Ownership & Insider Activity

AN2 Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch